Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Omega EVAR: Use of Fish Oil to Reduce Inflammation During Endovascular Abdominal Aortic Repair.

NCT03208920 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT03208920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03208920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Omega EVAR: Use of Fish Oil to Reduce Inflammation During Endovascular Abdominal Aortic Repair.
Lead sponsor
University of California, San Francisco
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2016
Completion date
August 28, 2018
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal aortic aneurysm, pad